OptimizeRx Corp (OPRX) (Q3 2026) Earnings Call Highlights: Margin Expansion and Programmatic ...
OptimizeRx Corp (OPRX) beat Q3 2026 estimates with 29% adjusted EBITDA margins and advancing DSP integrations, but a 17% revenue drop and reduced full-year outlook weigh on the near-term picture. Related Stocks: OPRX ,